Redact Sensitive Information with 99% Accuracy
Synchrogenix has processed over 8000 reports and has completed 65+ European Medicines Agency (EMA) Policy 0070 submissions using its ClinGenuity Redaction Management Service (CRMS), an artificial intelligence (AI)-enabled redaction technology solution.
Our solution provides anonymization and redaction services for redaction and advanced anonymization of Clinical Trial Data in the public domain. It is supported by expert reviewers who ensure that trials with specific challenges, such as small populations or rare diseases, receive the customized approach they require. Additionally, our experts assist sponsors with the authoring of anonymization reports.
Health Canada's Public Release of Clinical Information Initiative
Head over to the Synchrogenix blog to learn more about Health Canada's Public Release of Clinical Information (PRCI) initiative.
